Citigroup »

Turn Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Turn Therapeutics (TTRX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Turn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Turn Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Turn Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-09-30 $68k 4.7k 14.39

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)

View all positions for Citigroup

Top funds holding Turn Therapeutics

Steel Peak Wealth Management
Ieq Capital
Geode Capital Management
DDFG
Vanguard Capital Management
Millennium Management
BlackRock
Aaron Wealth Advisors
Tamar Securities
Royal Bank of Canada
Bridgewater Advisors
Citadel Advisors
HighTower Advisors
Brown Brothers Harriman & Co.
Leucadia National Corporation

View all funds holding Turn Therapeutics